Insider Stock Trading History of Ho Carole


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ho Carole since year 2005. The trader's CIK number is 1724605. At the time of this reporting, Ho Carole is the Chief Medical Officer of Denali Therapeutics Inc. . (stock ticker symbol DNLI). See this page for all insider trading activities at Denali Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Ho Carole since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-03 DNLI Denali Therapeutics Inc. Sale 17,500 18.80 328,930
2018-11-15 DNLI Denali Therapeutics Inc. Sale 17,500 18.07 316,155
2018-10-01 DNLI Denali Therapeutics Inc. Sale 17,500 21.72 380,100
2018-09-04 DNLI Denali Therapeutics Inc. Sale 17,500 19.05 333,375
2018-08-29 DNLI Denali Therapeutics Inc. Sale 17,500 18.04 315,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Carole (Chief Medical Officer of Denali Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.